Once-Weekly Diabetes Treatment Gets FDA OK 
MyFox Houston By Crystal Phend, Senior Staff Writer, WASHINGTON -- The delay is over for diabetes drug Bydureon (exenatide extended-release), with FDA approval making it the first once-weekly treatment for type 2 disease.Amylin's once-a-week diabetes injection wins FDA approval after 2 previous
Read More

MyFox Houston By Crystal Phend, Senior Staff Writer, WASHINGTON -- The delay is over for diabetes drug Bydureon (exenatide extended-release), with FDA approval making it the first once-weekly treatment for type 2 disease.Amylin's once-a-week diabetes injection wins FDA approval after 2 previous









